收藏切换
Brief analysis and Pondering on Pharmacovigilance in Pediatric Clinical Trials
收藏切换
Huanhuan CUI, Wendong LIU, Xiaohan WANG, Haixue WANG, Xian SU*
Chinese Journal of Pharmaceuticals | 2022, 53(11) : 1551 - 1557
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2022, 53(11): 1551-1557
Brief analysis and Pondering on Pharmacovigilance in Pediatric Clinical Trials
Full
Huanhuan CUI, Wendong LIU, Xiaohan WANG, Haixue WANG, Xian SU*
Affiliations
  • Center for Drug Evalution, National Medical Products Administration, Beijing 100022
Published: 2022-11-10 doi: 10.16522/j.cnki.cjph.2022.11.004
Outline
收藏切换

Refer to the EU Guidelines for pharmacovigilance of pediatric medicines, this paper analyzed the characteristics of adverse reactions in pediatric clinical trials and pediatric populations, and the main points of pharmacovigilance in pediatric populations. The pediatric population is in the stage of growth and development. The frequency and nature of adverse reactions are different from that of adults. According to the physiological and pathological characteristics of the pediatric population, they should be distinguished in terms of adverse reaction reporting and treatment, risk control, signal management, regular safety reports, and post-marketing research. Taking into account the current situation of pharmacovigilance construction during clinical trials in China, accelerate the establishment of a pharmacovigilance system for pediatric clinical trials and strengthen the protection of subjects in pediatric populations.

pediatric  /  pharmacovigilance  /  clinical trial  /  EU
崔欢欢, 刘文东, 王晓晗, 王海学, 苏娴. 儿童临床试验药物警戒浅析与思考. 中国医药工业杂志, 2022 , 53 (11) : 1551 -1557 . DOI: 10.16522/j.cnki.cjph.2022.11.004
Huanhuan CUI, Wendong LIU, Xiaohan WANG, Haixue WANG, Xian SU. Brief analysis and Pondering on Pharmacovigilance in Pediatric Clinical Trials[J]. Chinese Journal of Pharmaceuticals, 2022 , 53 (11) : 1551 -1557 . DOI: 10.16522/j.cnki.cjph.2022.11.004
Year 2022 volume 53 Issue 11
102
16
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.11.004
  • Receive Date:2022-08-23
  • Online Date:2026-11-12
  • Published:2022-11-10
Article Data
Affiliations
History
  • Received:2022-08-23
Affiliations
    Center for Drug Evalution, National Medical Products Administration, Beijing 100022
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2022.11.004
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT